
Boston Gene Showcases AI Disease Modeling Platform at JSMO 2026
BostonGene Showcases AI Disease Modeling at JSMO 2026 to Advance Precision Oncology BostonGene is set to highlight the capabilities of its advanced disease modeling platform at the 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO 2026), taking…












